Ureteroscopy and Laser Stone Fragmentation Is Safe and Tends to Improve Renal Function in Patients with Chronic Kidney Disease: Prospective Outcomes with a Minimum Follow-Up of 6 Months

医学 输尿管镜检查 肾脏疾病 肾功能 肾病科 泌尿科 输尿管 外科 前瞻性队列研究 肾结石病 人口统计学的 肾结石 内科学 人口学 社会学
作者
Thomas Reeves,Amelia Pietropaolo,Bhaskar Kumar Somani
出处
期刊:Journal of Endourology [Mary Ann Liebert, Inc.]
卷期号:34 (4): 423-428 被引量:11
标识
DOI:10.1089/end.2019.0784
摘要

Introduction: The role and long-term follow-up of ureteroscopy and laser stone treatment (URSL) in patients with chronic kidney disease (CKD) is unclear. Given conflicting results and a lack of robust data, we looked at the results of URSL in patients with CKD. Methods: Over a 6.5-year period (March 2012–July 2018), prospective outcomes were recorded for consecutive patients who underwent URSL for ureteral or renal stones. The inclusion criteria were all patients with CKD II–V. Renal function was checked preoperatively and at a minimum of 6 months postprocedure. Data were collected and analyzed for patient and stone demographics, procedural and postoperative details, and complications. Results: Over the study period, 277 patients with preoperative CKD stage II–V were included with a male:female ratio of 188:89 and a mean age of 66.6 years. The mean preoperative estimated glomerular filtration rate (eGFR) (mL/minute) was 63 (range: 14–89, ±18) with 167 (60.2%) CKD II, 70 (25.2%) CKD IIIa, 27 (9.7%) CKD IIIb, 10 (3.6%) CKD IV, and 3 (1%) CKD V patients. The mean single stone size was 9.6 mm (range: 3–37 mm, ±5.2) and 35.3% had multiple stones. The stone was located in the ureter for 112 patients, kidney for 137 patients, with 28 patients who had stones in both ureter and kidneys. A pre- and postoperative stent was present in 34.3% to 60% and 82.6% to 100% of patients, respectively, with an access sheath used in 103 (37.8%). The mean operative time was 44.5 minutes, with a stone-free rate of 91.6%. Postoperatively the mean eGFR improved to 68 (±20) ( p < 0.002). Complications occurred in 22 (7.9%) patients of which 18 were Clavien I/II and 4 were Clavien III/IV complications. Conclusion: URSL is safe and effective in patients with CKD with most patients discharged the same day of surgery. For majority of patients with both ureteral and renal stones, the renal function either stayed stable or improved after ureteroscopy on a long-term follow-up irrespective of their underlying CKD status.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
孤独巡礼完成签到,获得积分10
刚刚
刚刚
顺心行天完成签到,获得积分10
刚刚
科研通AI6.4的应助被陆梦鱼采纳,获得10
刚刚
昱鱼七seven完成签到,获得积分10
1秒前
顾高源发布了新的文献求助10
1秒前
1秒前
1秒前
阿俊1212发布了新的文献求助10
1秒前
123的应助被科研通管家采纳,获得10
1秒前
Jasper的应助被听音乐的可可采纳,获得10
1秒前
英姑的应助被科研通管家采纳,获得10
1秒前
NexusExplorer的应助被科研通管家采纳,获得10
2秒前
boluo666完成签到,获得积分10
2秒前
苹果大福完成签到,获得积分10
2秒前
Orange发布了新的文献求助10
2秒前
隐形曼青的应助被科研通管家采纳,获得10
2秒前
ttchen的应助被科研通管家采纳,获得10
2秒前
DMSO完成签到,获得积分10
2秒前
2秒前
哆啦A梦的小小王完成签到,获得积分10
2秒前
城北徐公完成签到,获得积分10
2秒前
田様的应助被科研通管家采纳,获得10
2秒前
斯文的觅波完成签到 ,获得积分10
2秒前
Pluto0o的应助被科研通管家采纳,获得10
3秒前
tRNA完成签到,获得积分10
3秒前
3秒前
3秒前
无极微光的应助被科研通管家采纳,获得20
3秒前
打打的应助被Guo采纳,获得30
3秒前
上官若男的应助被科研通管家采纳,获得10
3秒前
轻松乐巧完成签到,获得积分10
3秒前
尘曦完成签到,获得积分10
4秒前
hahaha完成签到,获得积分10
4秒前
seventeen关注了科研通微信公众号
4秒前
4秒前
阿哩哇啦完成签到 ,获得积分10
4秒前
4秒前
田様的应助被yyyy采纳,获得10
4秒前
赵童童童发布了新的文献求助10
4秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Energie-Contracting 1500
Klimaschutzrecht durch den Energiesektor im Mehrebenensystem – Ein Rechtsvergleich 1000
Oncology Clinical Trials: Successful Design, Conduct, and Analysis, Second Edition 800
Sustainable Engineered Micro/Nanofibers and Hybrid Nanocomposites for Environmental Remediation 400
Ecotourism 400
Liquidus diagram and viscosity estimation in pseudo-binary system Li2B6O10–LiF 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8076652
求助须知:如何正确求助?哪些是违规求助? 9494616
关于积分的说明 21382290
捐赠科研通 7644690
什么是DOI,文献DOI怎么找? 3400174
关于科研通互助平台的介绍 2529895
邀请新用户注册赠送积分活动 2438810